Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹16 Cr₹13 Cr₹9.65 Cr₹6.17 Cr₹5.39 Cr

What is the latest Total Non-Current Liabilities ratio of BAFNA PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of BAFNA PHARMACEUTICALS is ₹16 Cr based on Mar2025 Standalone results.
Year Total Non-Current Liabilities
Mar2025₹16 Cr
Mar2024₹13 Cr
Mar2023₹9.65 Cr
Mar2022₹6.17 Cr
Mar2021₹5.39 Cr

How is Total Non-Current Liabilities of BAFNA PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹16 Cr
28.69
Mar2024 ₹13 Cr
32.20
Mar2023 ₹9.65 Cr
56.49
Mar2022 ₹6.17 Cr
14.52
Mar2021 ₹5.39 Cr -

Compare Total Non-Current Liabilities of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹274.9 Cr -10.6% -8% 50.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-10.6%

-8%

50.5%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses